Changes in N-terminal pro b-type natriuretic peptide according to SGLT2 inhibitor utilization patterns in patients hospitalized for decompensated heart failure: a prospective cohort study

Back

ESC Professional Premium Access

Changes in N-terminal pro b-type natriuretic peptide according to SGLT2 inhibitor utilization patterns in patients hospitalized for decompensated heart failure: a prospective cohort study

Session: Biomarkers in acute heart failure: latest findings

Topic: Pharmacotherapy

Speaker: Doctor P. Theofilis (Athens, GR)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Doctor Panagiotis Theofilis

Hippokration General Hospital, Athens (Greece)

0 follower

5 more presentations in this session

Prognostic value of alveolar surfactant type-B in acute heart failure: a long-term comparative analysis vs NT-proBNP

Speaker: Associate Professor F. Bursi (Milan, IT)

Eicosanoids in coronary sinus negatively correlate with natriuretic peptides in heart failure with reduced ejection fraction: insights from Eicosanoids in Human Heart Failure Study

Speaker: Doctor P. Kala (Prague, CZ)

The association between circulating B cell count and clinical outcomes in patients with heart failure

Speaker: Doctor Y. Kobayashi (Yamagata, JP)

The dynamics of urine sodium concentration after intra-venous furosemide in patients with acute heart failure

Speaker: Doctor Y. Fujimoto (Tokyo, JP)

Basal natriuresis as a predictor of diuretic resistance and clinical evolution in acute heart failure

Speaker: Doctor E. Scatularo (Buenos Aires, AR)

Access the full session

Biomarkers in acute heart failure: latest findings

Speakers: Doctor P. Theofilis, Associate Professor F. Bursi, Doctor P. Kala, Doctor Y. Kobayashi, Doctor Y. Fujimoto...

Access

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources